nowson-guidelinesforthemanagement-2004.pdf (328.27 kB)
Guidelines for the management of postmenopausal osteoporosis for GPs
journal contribution
posted on 2004-10-01, 00:00 authored by S O'Neill, P Sambrook, T Diamond, P Ebeling, L Flicker, D Findlay, M Fiatarone-Singh, A MacLennan, A Markwell, Caryl NowsonCaryl Nowson, N Pocock, L Ferris, S Lord, M WilliamsonBACKGROUND : Since the last series of guidelines on the management of osteoporosis from Osteoporosis Australia was published in Australian Family Physician (October 2002), there have been further advances in our understanding of the treatment involved in both the prevention of bone loss and the management of established osteoporosis.
OBJECTIVE : This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies.
DISCUSSION : Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonatesr raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling.
OBJECTIVE : This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies.
DISCUSSION : Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonatesr raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling.
History
Journal
Australian family physicianVolume
33Issue
10Pagination
910 - 919Publisher
Royal Australian College of General PractitionersLocation
Jolimont, Vic.Link to full text
ISSN
0300-8495Language
engNotes
Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.Publication classification
C1 Refereed article in a scholarly journalCopyright notice
2004, Australian Family PhysicianUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC